CTIS2022-503114-23-00招募中1 期
STML-ELA-0222
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 640
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
A multicenter, Phase 1b, double-blind, placebo-controlled study to evaluate the safety and tolerability, and the efficacy of si-544 in adults with psoriasis vulgaris or psoriatic arthritisCTIS2023-507393-40-00selectION Therapeutics GmbH40
进行中（未招募）
1 期
A phase Ib study to investigate the safety and effect of BR-003Patients planned for open or percutaneous posterior spinal stabilisation with 4 or 6 pedicle screws with a diameter of 5 to 7.5 mm (inclusive), with or without concomitant posterolateral fusion, vertebral augmentation, intervertebral body fusion devices, osteotomies, and posterior decompression.CTIS2024-516338-37-00SentryX B.V.12
进行中（未招募）
1 期
A SINGLE-CENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF REPEAT DOSES OF ARM210 IN HEALTHY SUBJECTS.Cardiac arrhythmiasMedDRA version: 20.0Level: HLGTClassification code: 10007521Term: Cardiac arrhythmias Class: 10007541CTIS2023-509086-20-00Armgo Pharma Inc.8
进行中（未招募）
1 期
Bioequivalence clinical trial of two formulations of linagliptiHealthy volunteersCTIS2023-506562-31-00aboratorios Normon S.A.36
进行中（未招募）
1 期
Bioequivalence of Eltrombopag 75 mg Film-Coated Tablets in Healthy Subjects Under Fed Conditions.Aplastic anemia, ThrombocytopeniaMedDRA version: 20.0Level: LLTClassification code: 10002969Term: Aplastic anemia Class: 10005329MedDRA version: 20.0Level: PTClassification code: 10043554Term: Thrombocytopenia Class: 100000004851CTIS2022-502702-32-00Bluepharma Industria Farmaceutica S.A.72